10-Undecylenic Acid - CAS 112-38-9
Catalog number: 112-38-9
Category: Inhibitor
Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Molecular Formula:
C11H20O2
Molecular Weight:
184.28
COA:
Inquire
Targets:
Others
Description:
10-Undecylenic Acid, a long-chain fatty acid substance, could be used as a monomer in the polymerization and also a raw material in the syntheses of Pheromone (11Z)-hexadecenal.
Purity:
95%
Appearance:
Colorless or light yellow liquid
Synonyms:
undec-10-enoicacid;10-UNDECENOICACID;undecylenicacid;Undec-10-enoicacid;Undecenoicacid;112-38-9
Solubility:
10 mM in DMSO
Storage:
Store in a cool, dry place. Store in a tightly closed container.
MSDS:
Inquire
Application:
10-Undecylenic Acid could be used as a monomer in the polymerization and also a raw material in the syntheses of Pheromone (11Z)-hexadecenal.
Shelf Life:
As supplied, 2 years from the QC date provided on the Certificate of Analysis, when stored properly
Quantity:
Grams-Kilos
Boiling Point:
275ºC
Melting Point:
23-25ºC
Density:
0.912
InChIKey:
FRPZMMHWLSIFAZ-UHFFFAOYSA-N
InChI:
InChI=1S/C11H20O2/c1-2-3-4-5-6-7-8-9-10-11(12)13/h2H,1,3-10H2,(H,12,13)
Canonical SMILES:
C=CCCCCCCCCC(=O)O
1.An Involvement of PI3-K/Akt Activation and Inhibition of AIF Translocation in Neuroprotective Effects of Undecylenic Acid (UDA) Against Pro-Apoptotic Factors-Induced Cell Death in Human Neuroblastoma SH-SY5Y Cells.
Jantas D1, Piotrowski M2, Lason W1. J Cell Biochem. 2015 Dec;116(12):2882-95. doi: 10.1002/jcb.25236.
Undecylenic acid (UDA), a naturally occurring 11-carbon unsaturated fatty acid, has been used for several years as an economical antifungal agent and a nutritional supplement. Recently, the potential usefulness of UDA as a neuroprotective drug has been suggested based on the ability of this agent to inhibit μ-calpain activity. In order to verify neuroprotective potential of UDA, we tested protective efficacy of this compound against cell damage evoked by pro-apoptotic factors (staurosporine and doxorubicin) and oxidative stress (hydrogen peroxide) in human neuroblastoma SH-SY5Y cells. We showed that UDA partially protected SH-SY5Y cells against the staurosporine- and doxorubicin-evoked cell death; however, this effect was not connected with its influence on caspase-3 activity. UDA decreased the St-induced changes in mitochondrial and cytosolic AIF level, whereas in Dox-model it affected only the cytosolic AIF content. Moreover, UDA (1-40 μM) decreased the hydrogen peroxide-induced cell damage which was connected with attenuation of hydrogen peroxide-mediated necrotic (PI staining, ADP/ATP ratio) and apoptotic (mitochondrial membrane potential, caspase-3 activation, AIF translocation) changes.
2.Microwave-assisted pyrolysis of methyl ricinoleate for continuous production of undecylenic acid methyl ester (UAME).
Nie Y1, Duan Y1, Gong R1, Yu S1, Lu M1, Yu F1, Ji J1. Bioresour Technol. 2015 Jun;186:334-7. doi: 10.1016/j.biortech.2015.03.076. Epub 2015 Mar 19.
Undecylenic acid methyl ester (UAME) was continuously produced from methyl ricinoleate using a microwave-assisted pyrolysis system with atomization feeding. The UAME yield of 77 wt.% was obtained at 500°C using SiC as the microwave absorbent and heating medium. The methyl ricinoleate conversion and UAME yield from microwave-assisted pyrolysis process were higher than those from conventional pyrolysis. The effect of temperature on the pyrolysis process was also investigated. The methyl ricinoleate conversion increased but the cracking liquid yield decreased when the temperature increased from 460°C to 560°C. The maximum UAME yield was obtained at the temperature of 500°C.
3.Antifungal effects of undecylenic acid on the biofilm formation of Candida albicans.
Shi D, Zhao Y, Yan H, Fu H, Shen Y, Lu G, Mei H, Qiu Y, Li D, Liu W. Int J Clin Pharmacol Ther. 2016 May;54(5):343-53. doi: 10.5414/CP202460.
Undecylenic acid can effectively control skin fungal infection, but the mechanism of its fungal inhibition is unclear. Hyphal growth of Candida albicans (C. albicans) and biofilm formation have been well recognized as important virulence factors for the initiation of skin infection and late development of disseminated infection. In this study, we seek to investigate antifungal mechanisms of undecylenic acid by evaluating the virulence factors of C. albicans during biofilm formation. We found that undecylenic acid inhibits biofilm formation of C. albicans effectively with optimal concentration above 3 mM. In the presence of this compound, the morphological transition from yeast to filamentous phase is abolished ultimately when the concentration of undecylenic acid is above 4 mM. Meanwhile, the cell surface is crumpled, and cells display an atrophic appearance under scanning electron microscopy even with low concentration of drug treatment.
4.Polyelectrolyte-coated nanocapsules containing undecylenic acid: Synthesis, biocompatibility and neuroprotective properties.
Piotrowski M1, Jantas D2, Szczepanowicz K1, Łukasiewicz S3, Lasoń W2, Warszyński P4. Colloids Surf B Biointerfaces. 2015 Nov 1;135:8-17. doi: 10.1016/j.colsurfb.2015.07.029. Epub 2015 Jul 19.
The main objectives of the present study were to investigate the biocompatibility of polyelectrolyte-coated nanocapsules and to evaluate the neuroprotective action of the nanoencapsulated water-insoluble neuroprotective drug-undecylenic acid (UDA), in vitro. Core-shell nanocapsules were synthesized using nanoemulsification and the layer-by-layer (LbL) technique (by saturation method). The average size of synthesized nanocapsules was around 80 nm and the concentration was 2.5 × 10(10) particles/ml. Their zeta potential values ranged from less than -30 mV for the ones with external polyanion layers through -4 mV for the PEG-ylated layers to more than 30 mV for the polycation layers. Biocompatibility of synthesized nanocarriers was evaluated in the SH-SY5Y human neuroblastoma cell line using cell viability/toxicity assays (MTT reduction, LDH release). The results obtained showed that synthesized nanocapsules coated with PLL and PGA (also PEG-ylated) were non-toxic to SH-SY5Y cells, therefore, they were used as nanocarriers for UDA.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Products


CAS 2480-28-6 N2-Methyl-L-arginine

N2-Methyl-L-arginine
(CAS: 2480-28-6)

N2-Methyl-L-arginine, an analog of L-Arginine, is a selective L-arginine uptake inhibitor (Ki = 500 µM) which inhibits uptake of arginine by the lysosomal syste...

CAS 108289-44-7 CGP-1758 monomethanesulfonate

CGP-1758 monomethanesulfonate
(CAS: 108289-44-7)

CGP-1758 monomethanesulfonate is a new bio-active cephalosporin anti-biotic chemical comound synthesized by Ciba Geigy Ltd.

CAS 468741-42-6 BMS-554417

BMS-554417
(CAS: 468741-42-6)

BMS-554417 is a novel inhibitor of IGF-IR, which inhibits IGF-IR and insulin receptor kinase activity and proliferation in vitro, with the IC50 for proliferatio...

MK-B 251
(CAS: 40396-69-8)

MK-B 251 is a synthetic bio-active chemical.

CAS 58-46-8 Tetrabenazine

Tetrabenazine
(CAS: 58-46-8)

Tetrabenazine is a VMAT-inhibitor used for treatment of hyperkinetic movement disorder. It is a monoamine-depleting and a dopamine-receptor-blocking drug and is...

CAS 6899-04-3 DL-Glutamine

DL-Glutamine
(CAS: 6899-04-3)

DL-Glutamine is an unnatural amino acid and could be used for general biochemical research and drug synthesis.

CAS 3397-23-7 Ornipressin Acetate

Ornipressin Acetate
(CAS: 3397-23-7)

Ornipressin Acetate, an analogue of Vasopressin, is used as a vasoconstrict or haemostatic and renal agent.

CAS 317-52-2 Hexafluorenium bromide

Hexafluorenium bromide
(CAS: 317-52-2)

Hexafluronium bromide is .a cholinesterase inhibitor used in anesthesiology to prolong and potentiate the skeletal muscle relaxing action of suxamethonium durin...

Chemical Structure

CAS 112-38-9 10-Undecylenic Acid

Quick Inquiry

Verification code

Featured Items